Thursday, October 6, 2022, 10:00 am to Friday, October 7, 2022, 5:00 pm (registration required)
This two-day virtual symposium, organized by the National Human Genome Research Institute (NHGRI) and the University at Buffalo Center for Disability Studies, will address historical and present-day constructions of disability and ableism, with a focus on the history and lived experiences of people with disabilities in the context of genetics and genomics. This event aims to develop a fuller account of the lives and experiences of people with disabilities. Conversations will link disability rights to wider NIH discussions and around inclusivity, intersectionality, equity and social justice. Participants will discuss how disability and ability are connected to both historical and present-day eugenics, scientific and structural racism, heteronormativity, misogyny, imperialism and colonialism. Speakers will consider how scientific program funding language — and NIH communications — can better address the complexity of disability, health and wellness.
Friday, October 7, 2022, 12:00 pm to 1:00 pm
The first lecture in the 2022-2023 Director' Seminar Series will be presented by IRP senior investigator Andrea B. Apolo, M.D. Dr. Apolo’s work has focused on the development of targeted therapies, with a focus on angiogenesis, MET inhibitors, and immunotherapies for the treatment of urothelial cancer and rare genitourinary tumors, and to further our understanding of the pathways driving these diseases. She has investigated the patterns of oncogenic tyrosine-kinase pathway-related alterations in bladder cancer for targeted therapy approaches and has demonstrated the innate and adaptive immunomodulatory properties of cabozantinib. From these mechanisms, she has conducted pioneering research into novel therapies for bladder, kidney, and rare genitourinary cancers leading to FDA approval of avelumab for bladder cancer and cabozantinib/nivolumab combination for kidney cancer. In her talk, she will discuss the clinical development of these therapies, from phase 1 studies through phase 3 clinical trials for the treatment of urothelial cancer and rare genitourinary tumors.
Lectures in this series will be broadcast on NIH Videocast. Once in-person is feasible, they also will be held in Building 1, Wilson Hall (3rd Floor).
Monday, October 17, 2022, 8:10 am to 4:45 pm
Join the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as we celebrate 60 years of human development research and service to the United States.
The virtual symposium will focus on future directions of research related to pregnancy, reproductive health, child and adolescent development, intellectual and developmental disabilities, and medical rehabilitation. We'll also recognize several major accomplishments of the last 60 years and showcase our efforts to cultivate the next generation of researchers and promote an inclusive scientific culture.
Attendees can tune in virtually through the NIH videocast website for the livestream the day of the event. A recording of the symposium and other symposium materials will be made available after the event.
Wednesday, October 19, 2022, 2:00 pm to 3:00 pm
NIH Clinical Center (Building 10), Lipsett Amphitheater
This year's William E. Paul Lecture, part of NIH's Wednesday Afternoon Lecture Series (WALS), will be presented by IRP Distinguished Investigator Ronald Germain, M.D., Ph.D. Dr. Germain leads the Lymphocyte Biology Section (LBS) at the National Institute of Allergy and Infectious Diseases (NIAID), where his team has made numerous contributions to the understanding of the cell biology of antigen processing and presentation by MHC class I and especially class II molecules. It also has examined recognition of these ligands by T cells with a focus on the signaling mechanisms involved in ligand discrimination. Recently, the LBS has developed novel, highly multiplex section and volume imaging methods (Histo-cytometry and Ce3D) that allow an unprecedented analysis of cell phenotype, signaling, function, and location in complex tissue settings.
This lecture can also be viewed on NIH Videocast.
Wednesday, November 2, 2022, 2:00 pm to 3:00 pm
NIH Clinical Center (Building 10), Lipsett Amphitheater
This year's Astute Clinician Lecture, part of NIH's Wednesday Afternoon Lecture Series (WALS), will be presented by IRP Distinguished Investigator Steven M. Holland, M.D. Dr. Holland leads the Immunopathogenesis Section at the National Institute of Allergy and Infectious Diseases (NIAID), where his therapeutic and research programs take a fully integrated approach to infectious disease, incorporating the molecular genetics of the host and the pathogen as well as mechanisms of pathogenesis that allow the development and study of novel therapeutics. The integrated bench-to-bedside model is intrinsic to the Immunopathogenesis Section approach and is reflected in the close involvement of trainees (both M.D. and Ph.D.) in laboratory work and in the clinical appreciation of disease, which together add new insights into mechanisms of action and avenues of therapy. New protocols in Coccidioides infections and pathogenesis of mycobacterial infections are in progress.
This lecture can also be viewed on NIH Videocast.
Thursday, November 10, 2022, 9:00 am to 3:00 pm (registration required)
The Dr. Norman P. Salzman Memorial Fund was established in 1999 to present the annual Norman P. Salzman Memorial Symposium and Awards in Basic and Clinical Virology to outstanding postdoctoral fellows, graduate students, and postbaccalaureate trainees working in intramural laboratories at the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), Fort Detrick Laboratories, LEIDOS, United States Department of Agriculture (USDA), or Uniformed Services University of the Health Services (USUHS). The Symposium and Awards are hosted by the Foundation for the National Institutes of Health (FNIH), the NIH Virology Interest Group, and the Salzman Organizing Committee. The symposium, which will take place virtually this year, highlights current research of eminent extramural and NIH intramural virologists.
The Fund was established by Dr. Salzman’s family, colleagues and friends to remember the legacy of this noted pioneer in molecular biology and respected member of the NIH research community. Dr. Salzman's career spanned 40 years in virology research and he was among the first to characterize viral mRNAs and to visualize replicating viral DNA. Dr. Salzman’s achievements in virology are paralleled by the recognition that his laboratory was a training ground for many young scientists, several of whom have gone on to become important researchers on an international scale.
Thursday, April 27, 2023 to Friday, April 28, 2023 (register by April 23)
NIH Natcher Auditorium (Building 45)
RNA biology has emerged as one of the most influential areas in modern biology and biomedicine. The discovery of new classes of RNAs and their functions in a wide spectrum of biological processes has revolutionized molecular biology and has profound implications for clinical sciences. Key areas of current research include the elucidation of RNA biogenesis and structure, the identification of functions for various classes of RNAs, establishing the role of RNA in disease and the exploration of RNA-based-and RNA-targeted therapies.
Organized by the National Cancer Institute (NCI) Initiative in RNA Biology, this symposium will bring together internationally renowned experts in the field of RNA biology, with the focus on RNA processing; RNA structure and mechanism; non-classical RNAs; and RNA therapy.
The symposium offers the opportunity to learn more about the current status of RNA biology in development and disease, share research, network with leading figures in the field and discuss the use and implications of these advances for clinical applications.
